Patents for A61P 19 - Drugs for skeletal disorders (81,981)
08/2007
08/01/2007CN101007000A Therapeutic methods and compositions involving isoflavones
08/01/2007CN101006999A Therapeutic methods and compositions involving isoflavones
08/01/2007CN101006996A A drug for treating calculus in urinary system and hyperuricemia and its preparation method
08/01/2007CN101006822A Cartoon powdered ice cream containing vitamin A, D and calcium
07/2007
07/31/2007US7250420 Using a pyrrolo(2,3-d)pyrimidine compound
07/31/2007US7250399 Compounds having growth hormone releasing activity
07/31/2007US7250283 Nucleotide sequences coding polypeptide associate with fatty acid metabolism for use in diagnosis, prevention and treatment of obesity, diabetes and heart disease
07/31/2007CA2412596C Cyclic gmp-specific phosphodiesterase inhibitors
07/31/2007CA2240705C Cyclosporin-containing soft capsule preparations
07/26/2007WO2007083858A1 Composition comprising the extract of siegesbeckiae herba for preventing and treating arthritis and the use thereof
07/26/2007WO2007083759A1 Bone destruction inhibitor comprising anti-ccl20 antibody
07/26/2007WO2007083631A1 Method of stabilizing s-adenosyl-l-methionine and stabilized composition
07/26/2007WO2007083522A1 Gel-forming composition for medical use, devices for the application of the composition, and drug release controlling carrier
07/26/2007WO2007082914A2 Method of diagnosis and method of treatment
07/26/2007WO2007082352A1 Method of treatment, prophylaxis and diagnosis of pathologies of the bone
07/26/2007WO2007067478A3 P38 kinase inhibiting agents
07/26/2007WO2007044441A3 Use of pyrazolo [1 , 5 -a] pyrimidine derivatives for inhibiting protein kinases methods for inhibiting protein kinases
07/26/2007US20070174924 Transgenic mice containing TRP gene disruptions
07/26/2007US20070173548 Malonamic acids and derivatives thereof as thyroid receptor ligands
07/26/2007US20070173502 Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use
07/26/2007US20070173466 Methods of treating inflammatory diseases associated with bone destruction
07/26/2007US20070173454 Administering an agent that decreases or regulates the blood level, production, function or activity of gonadotropins-leutinizing hormone, follicle stimulating hormone, activin or follistatin; parkinson's disease
07/26/2007US20070172812 Tissue equivalent for transplantation and method for producing same
07/26/2007US20070172532 Complex Mixtures Exhibiting Selective Inhibition of Cyclooxygenase-2
07/26/2007US20070172458 IL-6/IL-6R fusion protein
07/26/2007CA2637635A1 Gel-forming composition for medical use, administration device for the composition, and drug release controlling carrier
07/26/2007CA2637350A1 Method of treatment, prophylaxis and diagnosis of pathologies of the bone
07/26/2007CA2636579A1 Compositions and methods of use for antibodies of dickkopf-1 and/or -4
07/25/2007EP1810674A1 Stable pharmaceutical composition containing carisoprodol and meloxicam
07/25/2007EP1809291A1 Pharmaceutical compositions for transdermal delivery
07/25/2007EP1499600B1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
07/25/2007EP1397364B1 Novel pyrrole derivatives as pharmaceutical agents
07/25/2007EP1370257B1 COMPOSITION FOR THE PREVENTION OF OSTEOPOROSIS consisting of A COMBINATION OF ISOFLAVONES AND POLYUNSATURATED FATTY ACIDS
07/25/2007EP1319184B1 Use of antibodies against specific mhc-peptide complexes
07/25/2007EP1282610B1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments
07/25/2007EP1263763B1 Tubulin binding ligands
07/25/2007EP1143985B1 Use of lactobacillus salivarius
07/25/2007CN1328285C Inhibitor of stem cell proliferation and uses thereof
07/25/2007CN1328247C N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists
07/25/2007CN1327910C Tissue equivalant for transplantation and process for producing the same
07/25/2007CN1327899C Gene recombined medicine of adenovirus carrier and p53 gene for treating proliferative diseases
07/25/2007CN1327898C Anti-inflammatory fatty alcohols and fatty acid esters useful as antigen carriers
07/25/2007CN1327872C 膏药 Plaster
07/25/2007CN1327871C Steaming medicinal liquor for treating intervertebral disc protrusion and hyperosteogeny
07/25/2007CN1327846C Sofflower injection and its prepn. method
07/25/2007CN1327830C Traditional Chinese medicine Babuji for treating arthritis, omitis and hyperosteogeny
07/25/2007CN101006097A Vla-4拮抗剂 Vla-4 antagonists
07/25/2007CN101006059A Substituted tetrahydroisoquinolines used in the form of MMP inhibitors, method for the production and use thereof in the form of drugs
07/25/2007CN101006058A Chemical compounds I
07/25/2007CN101005851A PTH-containing preparation for transmucosal administration
07/25/2007CN101005844A Muscarinic antagonists with PARP and SIR modulatng activity as agents for inflammatory diseases
07/25/2007CN101005843A Pyrrolotriazine kinase inhibitors
07/25/2007CN101003573A Human antibodies that bind human tnfalpha
07/25/2007CN101003538A [1,4]diazocino[7,8,1-hi]indole derivatives as antipsychotic and antiobesity agents
07/25/2007CN101002974A Cervical vertebrae health-care fomentation pillow, and its use method
07/25/2007CN101002919A Hot compress medicine for treating omitis, and its preparing method
07/25/2007CN101002910A Traditional Chinese medicine for treating bone medullitis
07/25/2007CN101002908A Plaster for treating osteopathy
07/25/2007CN101002901A Plaster for dispelling wind and removing dampness
07/25/2007CN101002894A Traditional Chinese medicine for treating rheumatosis and rheumatoid disease
07/25/2007CN101002873A Medicine for treating recurrent gout, and its preparing method
07/25/2007CN101002870A Traditional Chinese medicine tablets or capsule for treating fracture and injury, and its preparing method
07/25/2007CN101002868A Powder medicine for clearing and activating the channels and collaterals and relieving pain
07/25/2007CN101002867A External application medicine for treating vertebrae lumbales hyperosteogeny
07/25/2007CN101002864A Decoction for treating old lumbar soft tissue injury, and its preparing method
07/25/2007CN101002855A Medicine composition for treating hyperosteogeny, and its preparing method
07/25/2007CN101002851A Medicated wines used as antirheumatic
07/25/2007CN101002848A Medicine for treating recurrent uarthritis, and its preparing method
07/25/2007CN101002838A External application medicine powder for treating hyperosteogeny
07/25/2007CN101002814A Medical use of burdock total lignanoid
07/25/2007CN101002810A Dripping pills of schefflera arboricola, and its preparing method
07/25/2007CN101002808A Medical use of bidentate achyanthes total sterone
07/25/2007CN101002795A Method for preparing dialysis dry powder and dialysate of pure sodium bicarbonate
07/25/2007CN101002770A Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
07/25/2007CN101002757A Microemulsion of hypocrellin, and its preparing method
07/24/2007US7247630 Nitrogen compounds such as 3-(5-hydroxyhexyl)-1-methyl-1H-imidazo(2,1-f)purine-2,4(3H,6H)-dione, used for prophylaxis of diseases associated with cytokine intracellular signal transduction
07/24/2007US7247624 e.g. 5-Benzyloxy-2-(4-benzyloxy-phenyl)-3-methyl-1H-indole or salts for treating colon cancer
07/24/2007US7247618 Methods for inhibiting macrophage colony stimulating factor and c-FMS-dependent cell signaling
07/24/2007US7247608 FGF homolog polypeptides
07/24/2007US7247331 Isolating milk proteins by passing milk or whey over a cation-exchange resin, eluting the fraction retained by an aqueous salted solution and desalting and sterilizing the eluate; pharmaceutical and food compositions
07/24/2007US7247305 Amino acid sequences, DNA encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof
07/19/2007WO2007081031A1 Glycosyltransferase inhibitor
07/19/2007WO2007080898A1 Sustained-release hydrogel preparation
07/19/2007WO2007080885A1 Cycloalkanecarboxamide derivative and method for producing same
07/19/2007WO2007080882A1 Oxazolone derivative
07/19/2007WO2007080847A1 Mutant growth factor with altered receptor specificity and pharmaceutical composition containing the same
07/19/2007WO2007080659A1 AGENT FOR INCREASING BONE MINERAL CONTENT COMPRISING p-HYDROXYCINNAMIC ACID AS ACTIVE INGREDIENT
07/19/2007WO2007080630A1 AGENT FOR INCREASING BONE MINERAL CONTENT COMPRISING p-HYDROXYCINNAMIC ACID AS ACTIVE INGREDIENT
07/19/2007WO2007080191A1 6-phenyl-1h-imidazo[4, 5-c]pyridine-4-carbonitrile derivatives as cathepsin k and s inhibitors
07/19/2007WO2007031333A3 Improvements in or relating to amphoteric liposomes
07/19/2007WO2006125651A3 Ligustilide derivatives for the treatment of inflammatory disorders
07/19/2007WO2006037623A3 New nuclear transcription factors regulators
07/19/2007US20070167511 Medicinal composition for prevention or treatment of overactive bladder accompanying nervous disorder
07/19/2007US20070167503 Substituted benzoxazoles as estrogenic agents
07/19/2007US20070167501 Bicyclo derivative
07/19/2007US20070167483 Phenylalanine Enamide Derivatives
07/19/2007US20070167471 Substituted quinazoline compounds useful as p38 kinase inhibitors
07/19/2007US20070167457 2-(2-(4-Fluoro)phenoxyethyl)-1-((4-(2-methyl-5-phenyl)thiazolyl)carbonyl)-4-trifluoroacetylpiperazine; antidiabetic agent; non-insulin dependent diabetes, obesity, sleep disorder
07/19/2007US20070167451 BARBITURIC ACID DERIVATIVES AS INHIBITORS OF TNF-alpha CONVERTING ENZYME (TACE) AND/OR MATRIX METALLOPROTEINASES
07/19/2007US20070167445 Androgen receptor modulator compounds and methods